MARATTO

review · European Journal of Gastroenterology & Hepatology

The efficacy of Hemospray in managing bleeding related to gastrointestinal tumors: systematic review and meta-analysis

20242 citationsOctober 6 University

Abstract

This meta-analysis highlights Hemospray's efficacy in achieving immediate hemostasis in GI tumor-related bleeding, with potential benefits in reducing supplementary interventions and improving patient outcomes. Despite comparable rebleeding rates, Hemospray emerges as a valuable adjunctive therapy in managing malignant GI bleeding.

Research topics

  • Gastrointestinal Bleeding Diagnosis and Treatment
  • Hemostasis and retained surgical items
  • Gastrointestinal Tumor Research and Treatment

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.1097/meg.0000000000002828

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.